VEGFA and chronic asthma: Other studies with PA-treated animals have demonstrated decreased expression of IL-4, IL-5, IL-13, vascular endothelial growth factor A (VEGFA), and transforming growth factor (TGF)-β1 in acute and chronic asthma models [8,9].